WOK

+ Watchlist + Portfolio

WORK Medical Technology Group LTD

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $1.76
52-Week Range: $1.66 – $105,000.00
Market Cap: $7.64M
P/E (TTM): —
EPS (TTM): -51993.25
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 0.00
PEG Ratio: —
Return on Equity: -19.23%
Return on Assets: -6.73%
Gross Margin: 16.97%
Operating Margin: -65.35%
Profit Margin: -41.95%
Current Ratio: 1.36
Debt/Equity: 0.20
Total Debt: $6.62M
Free Cash Flow: $-2.16M
Revenue Growth: 19.10%
Earnings Growth: —
Enterprise Value: $5.75M

WOK Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$19.71M	$13.57M	$11.51M	$9.85M
Cost of Revenue	$15.29M	$9.42M	$8.64M	$7.50M
Gross Profit	$4.42M	$4.14M	$2.87M	$2.34M
Research & Development	$183.90K	$301.64K	$302.51K	$435.31K
Selling, General & Admin	$3.60M	$3.43M	$6.61M	$4.41M
Operating Expenses	$2.59M	$3.66M	$6.57M	$3.24M
Operating Income	$1.82M	$486.46K	-$3.70M	-$895.53K
EBITDA	$4.72M	$2.11M	-$1.70M	$344.66K
Pretax Income	$1.11M	$110.39K	-$3.67M	-$1.08M
Income Tax	$169.44K	$47.01K	-$125.29K	$119.05K
Net Income	$865.21K	$112.03K	-$3.49M	-$1.07M
Diluted EPS	61800.71	8002.14	-249451.29	-10414.24
Diluted Shares	14	14	14	103

WOK Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$731.18K	$1.60M	$6.56M	$4.09M
Receivables	$6.15M	$10.99M	$5.75M	$12.45M
Inventory	$4.36M	$4.62M	$3.18M	$2.46M
Current Assets	$16.61M	$22.15M	$20.83M	$20.46M
Total Assets	$25.54M	$29.96M	$36.25M	$33.16M
Current Liabilities	$14.26M	$18.92M	$20.18M	$11.97M
Total Debt	$6.30M	$9.10M	$13.47M	$6.42M
Total Liabilities	$14.35M	$18.97M	$20.18M	$11.99M
Retained Earnings	$9.51M	$9.58M	$6.08M	$4.96M
Shareholders' Equity	$10.00M	$9.88M	$13.19M	$18.34M
Working Capital	$2.35M	$3.23M	$647.03K	$8.48M
Net Debt	$5.48M	$7.40M	$6.91M	$2.30M

WOK Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$2.26M	$2.21M	-$2.23M	$6.24M
Capital Expenditure	-$2.01M	-$583.30K	-$9.26M	-$1.33M
Free Cash Flow	-$4.27M	$1.63M	-$11.49M	$4.91M
Depreciation & Amortisation	$3.26M	$1.60M	$1.41M	$923.11K
Investing Cash Flow	-$1.35M	-$583.30K	-$9.06M	-$7.61M
Financing Cash Flow	$3.57M	-$728.72K	$15.66M	-$898.21K
Net Change in Cash	-$39.89K	$897.71K	$4.36M	-$2.26M

WOK Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q3 2025	Q1 2026
Cash & Equivalents	$2.00M	$4.09M	$3.25M
Receivables	$7.11M	$12.45M	$5.09M
Inventory	$2.98M	$2.46M	$1.93M
Current Assets	$21.58M	$20.46M	$21.59M
Total Assets	$34.71M	$33.16M	$48.31M
Current Liabilities	$18.98M	$11.97M	$15.82M
Total Debt	$13.04M	$6.42M	$6.62M
Total Liabilities	$19.00M	$11.99M	$15.83M
Retained Earnings	$6.09M	$4.96M	$1.55M
Shareholders' Equity	$12.95M	$18.34M	$30.12M
Working Capital	$2.60M	$8.48M	$5.78M
Net Debt	$11.03M	$2.30M	$3.34M

Market Snapshot

About

WORK Medical Technology Group is a medical device company focused on spine and orthopedic implant systems. The company develops and commercializes innovative surgical solutions for spinal disorders and musculoskeletal conditions. WORK Medical aims to improve patient outcomes through advanced medical technology.